
Go to market strategy templates promise a repeatable structure: positioning, messaging, channel plan, sales enablement. A medtech founder fills in every field, launches on schedule, and the market still doesn't respond.
The template assumed a category the founder hadn't built yet, and no amount of template discipline substitutes for that missing step.
Key Takeaways
Watch the full episode on YouTube
A go-to-market template is a sequencing tool. It tells a founder what order to do things in. It does not tell a founder whether the thing they're about to sequence has a market to land in yet.
I covered this on an episode about how market engineering helps medtech startups raise capital:
"The category is essentially setting up the rules of the game: the context, the language, everything. As a result, founders, medtech startups, tend to focus on product, FDA, hiring, and execution. What matters is defining the category, or redesigning one, aligning your messaging so people understand you, building the narrative, and then driving demand with your go-to-market."
Every field in a standard go-to-market template lives inside that last clause. Templates are built to organize demand generation, channel selection, and sales enablement. None of that has anywhere to attach if the category, the messaging, and the narrative haven't been defined first.
The four disciplines aren't a menu a founder picks from. They're a sequence, and skipping ahead to the go-to-market step is the specific mistake a template makes easy.
"Your category is defining the problem, naming the category. Messaging is your positioning, your differentiation, your proofs. Narrative comes down to thought leadership, your point of view, market education. Then go-to-market: sales and marketing alignment, and then you launch your demand."
A go-to-market template can help a founder execute the last step well. It has nothing to say about the first three, which is exactly where most medtech go-to-market plans fail before anyone notices why.
"It's the sum of category, plus messaging, plus narrative, plus go-to-market. If any one of those pieces is missing, none of it's going to work."
That's the part a filled-in template hides. A founder can complete every section of a go-to-market document and still be missing category, messaging, or narrative entirely, because the template never asked for them explicitly.
Before a go-to-market template does any good, a founder needs a market defined well enough to go to. That's what a minimum viable category means in practice.
The framework treats category definition as several elements that have to converge before go-to-market makes sense: a real problem, a product built for it, and language the market recognizes as its own. Skip that convergence and the go-to-market plan launches into empty space.
"The most common thing I see in medtech is a solution without a market."
That line describes most of the go-to-market templates that get filled in and shipped without results. The solution is real. The FDA clearance is real. The market the template assumes exists hasn't been built yet, and no channel plan fixes that gap.
A go-to-market template pulls a founder's attention toward the parts of the plan that feel most concrete: content calendars, channel mix, sales collateral. Those are also the cheapest parts to get wrong and the most expensive parts to fund without a category behind them.
Every dollar spent executing a go-to-market template before category, messaging, and narrative exist is a dollar spent making an undefined market look busier. It doesn't make the market bigger.
This is the same mechanism covered in what a go-to-market strategy misses when the market hasn't formed yet: the plan can be executed perfectly and still fail, because execution was never the missing piece.
Founders who reverse the order, category and narrative first, go-to-market template second, spend the same budget on work that compounds instead of work that has to be redone once the category finally gets defined.
In my experience working with medtech founders, the ones who ask for a go-to-market template are usually further from ready than they think. A template answers "what order do I do things in." It never answers "does this market exist yet."
The founders who get this right treat the template as the last document they fill in.
Category, messaging, and narrative come first, built through the same discipline covered in the 5 pillars of market engineering. The go-to-market template becomes useful only once there's an actual category on the other side of it.
Go-to-market templates organize execution: channels, messaging cadence, sales enablement. They don't define the category a product competes in.
Early-stage medtech startups often fill in every field without ever defining the category, which is why the plan can be executed perfectly and still produce no market response.
A founder needs a defined category, a clear message that differentiates the product, and a narrative the market recognizes. Those three have to exist before a go-to-market template has anything real to organize. Skipping to the template first is the most common reason go-to-market plans fail in medtech.
A minimum viable category is the smallest defined market a product needs before go-to-market execution makes sense: a real problem, a product built to solve it, and language the market already recognizes.
Without it, a company has a solution without a market to sell it into.
If you're doing this yourself. The State of MedTech covers how founders define a category before they ever open a go-to-market template.
If you want it engineered with you. MarketCraft takes on a small number of medtech teams each quarter, starting with The Market Engineering Audit. For teams about to execute a go-to-market plan, the audit checks whether the category it assumes exists yet.
How Market Engineering Helps MedTech Startups Raise Capital covers the full category, messaging, narrative, and go-to-market sequence referenced throughout this piece. Subscribe wherever you listen to podcasts.
Omar Khateeb is the founder of MarketCraft and host of The State of MedTech, the number one podcast in the medtech industry.
He works with medtech founders and commercial leaders on market engineering, commercialization strategy, and revenue growth. Visit marketcraft.ai or subscribe to The State of MedTech for weekly conversations with the people building the future of medical devices.